drugset / Trial / NCT05244954

Comparing Chemoprevention Approaches for School-based Malaria Control

NCT05244954

RandomizedParallel-groupSingle-blindPrevention

Summary

This is an individually randomized, controlled, single blind three arm clinical trial of malaria chemoprevention strategies Arm 1: Intermittent screening and treatment (IST) - students will receive treatment if they have a positive high sensitivity rapid diagnostic test (RDT). Arm 2: Intermittent preventive treatment (IPT) - all students will receive treatment. Arm 3: Control - students will receive standard of care (no preventive treatment). Outcomes include P. falciparum infection and parasite density, gametocyte carriage and gametocyte density, anemia, cognitive function and educational testing, as well as infection prevalence in student's households to assess the impact on transmission.

Timeline

Start
2022-02-01
Primary completion
2022-08-26
Completion
2022-08-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule
Subject Dihydroartemisinin-piperaquine Unknown